BTIG Reiterates Neutral Rating on Bionano Genomics (BNGO)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Ladenburg Thalmann Downgrades Bionano Genomics (BNGO) to Neutral
November 15, 2024 6:42 AM ESTLadenburg Thalmann analyst Jeffrey Cohen downgraded Bionano Genomics (NASDAQ: BNGO) from Buy to Neutral.
For an analyst ratings summary and ratings history on Bionano Genomics click here. For more ratings news on Bionano Genomics click here.
Shares of Bionano Genomics closed at $0.26 yesterday.
... More